CPBTD
NVO

Central Pacific Bank - Trust Division’s Novo Nordisk NVO Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$239K Sell
6,300
-6
-0.1% -$277 0.03% 416
2026
Q2 		$302K Buy
6,306
+6
+0.1% +$258 0.03% 398
2026
Q1 		$232K Buy
+6,300
New +$299K 0.03% 427
2024
Q4 		– Sell
-6,172
Closed -$735K – 909
2024
Q3 		$735K Sell
6,172
-6,619
-52% -$883K 0.09% 221
2024
Q2 		$1.83M Buy
12,791
+454
+4% +$60.2K 0.22% 105
2024
Q1 		$1.57M Buy
+12,337
New +$1.47M 0.2% 128

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Central Pacific Bank - Trust Division's NVO Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Novo Nordisk (NVO) stake by 0.1% in Q3 2026, selling an estimated $277 and leaving 6,300 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #416.

Central Pacific Bank - Trust Division first reported a position in NVO in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.83M in Q2 2024. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Central Pacific Bank - Trust Division held 6,300 shares of Novo Nordisk worth $239K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 6 Novo Nordisk shares in Q3 2026, an estimated $277.
  • Novo Nordisk made up 0.03% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #416 holding.
  • Central Pacific Bank - Trust Division first reported a position in Novo Nordisk in Q1 2024 and has held it in 6 quarters since.
  • Central Pacific Bank - Trust Division's Novo Nordisk position peaked at $1.83M in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.